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ABSTRACT
Assay, Purification, and Characterization of a
Pantetheine Hydrolyzing Enzyme
from Pig Kidney
by
Carl T. Wittwer, Doctor of Philosophy
Utah State University, 1982
Major Professor: Dr. R. Gaurth Hansen
Department: Chemistry and Biochemistry
A microsomal glycoprotein hydrolyzing pantetheine to pantothenate
and cysteamine has been solubilized and purified to homogeneity as
determined by sodium dodecylsulfate electrophoresis.

Four rapid,

independent assays of pantetheine hydrolysis are described and
compared along with a method for localizing enzymatic activity on
polyacrylamide gels.

The enzyme is solubilized on exposure to butanol

and purified by heat treatment, (NH 4 )2so fractionation, hydrophobic
4
chromatography, and hydroxyapatite chromatography. The glycoprotein,
purified 5600-fold in 22%yield, has a specific activity of 14 µmoles
pantothenate produced/min/mg of protein, 35 times that previously
reported.

The enzyme has a pH optimum of 9.0-9.5 and a Km of 20 µM

for D-pantetheine.

Its molecular weight has been estimated by gel

filtration (54,000) and sodium dodecylsulfate electrophoresis
(60,000).

Amino acid analysis indicates a high content of isoleucine

(11 .3 mole %) and phenylalanine (7.4 mole %) with an absorbancy index

E~ ~m (280 nm) of 11.3. Galactose, mannose, fucose, and glucose are
present in decreasing concentrations totaling 90 µg of neutral hexoses

viii
per mg of protein.

Galactosamine and sialic acid are also present.

The enzymatic hydrolysis of various pantetheine analogs indicate the
enzyme's specificity is high for the pantothenate moiety but low for
the cysteamine portion.
11

The enzyme should be useful in routine

total 11 pantothenate determinations in tissues.

(100 pages)

CHAPTER I
INTRODUCTION
D-Pantetheine is an intermediate compound between the vitamin
pantothenic acid, and the coenzymes, phosphopantetheine, and coenzyme
A.

Pantothenate derivatives function widely in central metabolism and

mediate many reactions in carbohydrate, lipid, and amino acid
metabolism.

Abiko (1975) has listed 72 enzymatic reactions that

involve coenzyme A or phosphopantetheine as cofactors.

The enzymatic

hydrolysis of pantetheine to pantothenate and cysteamine is of
interest as part of the catabolic pathway of these cofactors.
The purpose of this study is to reliably assay, purify to
homogeneity, and characterize a pantetheine hydrolyzing enzyme from
pig kidney .
Pantothenic Acid and Its Coenzymes
Discovery and Characterization
Pantothenic acid.

Williams et al. (1933) identified an unknown

substance in diverse biological sources that was a potent growth
factor for yeast.

Because of its widespread occurrence and acidic

properties, it was called "pantothenic" acid, derived from the Greek,
meaning "from everywhere".

When both the chick anti-dermatitis factor

(Woolley et al. 1939) and the liver filtrate factor of rats (Subbarow
and Hitchings 1939) turned out to be pantothenic acid, its importance
in animal nutrition warranted its inclusion as a vitamin.

Studies on

its isolation and chemical structure eventually led to its synthesis

2

(Williams and Major 1940).

Although it was assumed that pantothenic

acid functioned as part of a coenzyme like other vitamins, no
pantothenate coenzyme was found until 14 years after its initial
discovery.
Coenzyme A.

Lipmann (1945) found the acetylation of

sulfanilamide to depend on an enzyme-coenzyme system present in liver
homogenates.

The coenzyme of acetylation, or "coenzyme A" (CoA) was

later shown to be a pantothenate derivative (Lipmann et al. 1947) that
was also widely distributed (Kaplan and Lipmann 1948).

The structure

of CoA was determined enzymatically (Novelli et al. 1954), and it was
eventually chemically synthesized (Moffatt and Khorana 1961).
Pantetheine and pantethine.

Williams et al. (1949) described a

previously unidentified growth factor for Lactobacillus bulgaricus.
It was later found to contain 65-75% pantothenic acid by weight and to.
be a breakdown product of CoA

(Brown et a 1. 1950).

Its structura 1

determination and synthesis were achieved (Snell et al. 1950).
names

11

pantetheine 11 and

11

The

pantethine 11 were suggested for the sulfhydral

and disulfide forms, respectively, to indicate their relation to
pantothenic acid.

Majerus et al. (1965) later identified

4 1 -phosphopantetheine as the prosthetic group in the acyl carrier
protein of fatty acid synthesis.
The structures of these compounds and their relation to each
other are shown in Fig. 1.
are given in Table 1.

Alternative names of selected compounds

'Hydrolyzed by phosphatase

1

Hydrolyzed by am1dase

OH

.AA.A/··
H

H

t---pantoate----+--B-alan1ne----cysteamine--i
------pantothenate------t

i------ alethe1 n e - - - - - - ----------pantetheine-----------

t---------- phosphopantethe1 ne
-------------dephosphocoenzyme A - - - - - - - - - - - - - - - t
1-----------------coenzyme A------------------i

Figure l.

Structures and names of coenzyme A fragments.

w
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Table 1.

Synonyms for some Compounds in Pantothenate Metabolism.

Pantothenic Acid*
(R)-N-{2,4-dihydroxy-3,3-dimethyl-l-oxobutyl)-8-alanine**
D(+)-N-{2,4-dihydroxy-3,3-dimethylbutyryl)-8-alanine
chick antidermatitis factor
vitamin 8
vitamin 853
Pantetheine
N-{pantothenyl)-8-aminoethanethiol
2,4-dihydroxy-N-[3-[{2-mercaptoethyl)amino]-3-oxopropyl]-3,3dimethylbutanamide*
2,4-dihydroxy-N-[2-[(2-mercaptoethyl)carbamoyl]ethyl]-3,3dimethylbutyramide**
a,y-dihydroxy-8,8-dimethylbutyryl-8-alanyl-8-aminoethanethiol
Pantethine (the disulfide of pantetheine)
bis(N-pantothenyl-8-aminoethyl)disulfide
N,N'-[dithiobis[2,l-ethanediylimino(3-oxo-3,l-propanediyl]]bis[2,4-dihydroxy-3,3-dimethylbutanamide]*
N,N'-[dithiobis(ethyleneiminocarbonylethylene)]bis(2,4-dihydroxy3,3-dimethylbutyramide)**
Lactobacillus bulgaricus factor (L8F)
Pantosin
Cysteamine
2-aminoethanethiol* **
mercaptamine
8-mercaptoethylamine
2-aminoethyl mercaptan
thioethanolamine
decarboxycysteine
M~

8ecaptan
Cystamine (the disulfide of cysteamine)
2,2'-dithiobisethylamine*
2,2'-dithiobisethanamine**
8,8'-diaminodiethyl disulfide
bis[8-aminoethyl]disulfide
decarboxycystine
*Nomenclature used in Chemicals Abstracts through the Eighth
Collective Index, 1967-1971.
**Nomenclature used in Chemical Abstracts since the Eighth
Collective Index, 1972-to date.
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Biochemical Functions
Pantothenic acid is the vitamin moiety of CoA and phosphopantetheine, both of which carry acyl groups through thioester
bonds.

The S-acyl derivatives of these pantothenate coenzymes are

formed on oxidation of aldehydes, on oxidative decarboxylation of
a-keto acids, and from organic acids activated by ATP or GTP.

The

activated acyl groups may be transferred to other acceptors, or
modified by oxidation/reduction, carboxylation/decarboxylation,
hydration/dehydration, racemization, carbon skeleton rearrangement, or
formation of new carbon to carbon bonds.

The versatility of these

acylated coenzymes arises in part from the extended configuration of
pantetheine and in part from the reactivity conferred by the thioester
bond.
Generally, pantothenate derivatives mediate the metabolism of
carbohydrates, lipids, and amino acids.

Specifically, in the

tricarboxylic acid cycle, CoA funct i ons as an acyl acceptor for the
pyruvate and a-ketoglutarate dehydrogenase complexes, forming acetyl
CoA and succinyl CoA, respectively.

These CoA thioesters are also

formed on oxidative degradation of several amino acids.

The acetyl

group from acetyl CoA is the carbon source for the biosynthesis of
fatty acids, prostaglandins, ketone bodies, cholesterol, steroid
hormones, and other compounds.

Succinyl CoA is an essential precursor

for porphyrins and hence, hemoglobin and cytochromes.

In fatty acid

synthesis and degradation, pantothenate coenzymes carry the acids as
acyl groups through repetitive synthetic or degradative cycles.
thioester is a necessary intermediate in the degradation of

A CoA

6

cholesterol to bile acids.

Phosphopantetheine has been implicated in

the synthesis of peptide antibiotics (Lee and Lipmann 1977) through an
oligopeptide synthetic system that may be an evolutionary forerunner
of modern ribosomal protein synthesis (Lipmann 1971).

Coenzyme A

thioesters are the acyl donors for many acceptors, including choline
and cholesterol.

Some important compounds synthesized from

pantothenate derivatives are shown in Fig. 2.
Metabolic Regulation
Intermediary metabolism is inundated with pantothenate coenzymes.
There are several mechanistically unexplained correlations in the
literature between altered metabolic states and altered pantothenate
metabolism.

Rheumatoid arthritis results in low whole blood total

pantothenate (Barton-Wright and Elliott 19631 and patients with
systemic lupus erythematosus have lower bound/free ratios of whole
blood pantothenate (Slepyan et al. 1957).

In human chronic ulcerative

and granulomatous colitis, diseased colonic mucosa has low CoA
activity, even though blood pantothenate levels are normal
(Ellestad-Sayed et al. 1976).

Of particular current interest are

correlations between pantothenate derivatives and lipid metabolism.
Interest in pantothenate derivatives has increased recently as
associations between the derivatives and lipid metabolism have
appeared.

Altering pantothenate metabolism by oral administration of

pantethine effects lipid levels.

Pantethine has been shown to

decrease cholesterol ester synthesis in rat arterial wall extracts
(Shirai et al. 1979) and to decrease the serum cholesterol,
8-lipoprotein, and triglyceride levels in rats fed a high cholesterol

( Steroid
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Figure 2.

Some important compounds synthesized from pantothenate derivatives.
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diet (Shinomiya et al. 1980; Kajiyama et al. 1981).

Pantethine fed to

streptozotocin diabetic rats reduced levels of serum triglycerides,
free fatty acids, and s-hydroxybutyrate (Kameda and Abiko 1980).
Rabbits fed a high cholesterol diet had low density lipoprotein
cholesterol normalized upon treatment with pantethine, but high
density lipoprotein was increased (Tomikawa et al. 1982).

In diabetic

patients with hyperlipidemia, pantethine decreased serum cholesterol,
increased high density lipoprotein cholesterol, and normalized serum
and platelet lipid compositions (Hiramatsu et al. 1981).

In May of

1981, Dr. John Gilbert of Inveresk Research International, Edinburgh,
Scotland was sent antisera for the radioimmunological determination of
pantothenate in blood (Wyse et al. 1979) after administration of
pantethine to human volunteers.

In the past 5 years, Chemical

Abstracts lists over 30 patents granted on the synthesis and uses of
pantethine.
Not only does modified pantothenate metabolism effect lipid
levels, but altered lipid metabolism effects levels of pantothenate
derivatives .

The altered lipid metabolism of fasting and diabetes

(Smith et al. 1978; Reibel et al. 198lb), and clofibrate
administration (Voltti et al. 1979), correlates with grossly elevated
liver and heart CoA levels in rats.

Changes in tissue CoA levels

could conceivably arise from changes in pantothenate supply or
transport. However, concentration and radioactive incorporation
studies show that supply and transport are unimportant in most cases
(Smith et al. 1978; Smith 1978; Smith and Savage 1980; Reibel et al.
198la; Voltti et al. 1979; Ellestad-Sayed et al. 1976).

Alterations

9

in the activity of biosynthetic or degradative enzymes of CoA are
suspected.
Biosynthesis and Degradation of
Coenzyme A
The biosynthesis and degradation of CoA have been reviewed by
Abiko (1975).

The relevant reactions are shown in Fig. 3.

Intracellular control of CoA levels occurs within hours, following the
fasting/feeding cycles of rats (Smith et al. 1978).

The

phosphopantetheine prosthetic group of acyl carrier protein also turns
over in a few hours, whereas the half life of the protein is a matter
of days (Tweto and Larabee 1972).

A very dynamic control process is

apparent that has only begun to be studied.
The enzymatic control point varying CoA levels remains unknown.
It may be in either the biosynthesis, or the degradation of CoA, or
both.

In the case of clofibrate induced hyperlipidemea, Voltti et al.

(1979) favored inhibition of the enzymes of CoA degradation, whereas
Reibel et al. (198la), studying diabetes and fasting, believed the
regulation to be biosynthetic.

Most workers hypothesize control

points from indirect evidence of intermediate levels or kinetic
incorporation studies.

Only Skrede and Halvorsen (1979), working with

clofibrate treated rats, have attempted to measure the specific
activity of the enzymes involved, and they measured only pantothenate
kinase, acid phosphatase, and -nucleotide pyrophosphatase activities
(Fig. 3).

An unambiguous identification of the enzymatic control

point would allow more detailed regulation studies on lipid metabolism

3'
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---~APo-ACP----
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in diabetes and hyperlipidemia with eventual academic, if not
clinical, implications.
Metabolic Significance of
Pantetheine Hydrolysis
The enzymatic hydrolysis of pantetheine to pantothenate and
cysteamine may be part of the control process regulating CoA levels.
It is the only specific step in the degradation of CoA (Abiko 1975;
Skrede 1973).

It is also the only catalytic step in Figure 3 whose

enzyme has not been studied sufficiently to assign an Enzyme
Commission code number (IUB 1979).
Cysteamine, the other product besides pantothenate in the
enzymatic hydrolysis of pantetheine, is also of interest.

It has long

been known as a radioprotective agent (Bacq et al. 1953) and shows
promise in treating cystinosis (Yudkoff et al. 1981).

It is an

antidote for acetaminophen (Tylenol, Paracetamol) poisoning (Prescott
et al. 1976) and is a potent depletor of pituitary prolactin (Millard
et al. 1982).

Cysteamine is also a precursor of taurine

(2-aminoethanesulfonic acid), and the production of taurine via
pantetheine and cysteamine may be important physiologically (Federici
et a1 . 1980) .
Liberation of Pantothenate from Biological Samples
Assay of Pantothenate
Bioassay, or more often microbiological assay, of pantothenic
acid are the usual methods of assay, although a radioimmunoassay has
recently been reported (Wyse et al. 1979).

Early comparisons between

12

bioassay and microbiological assay were disparate (Jukes 1947).
Pantothenate available on bioassay was greater than that determined
microbiologically.

Various chemical and enzymatic treatments of

biologic samples were used to increase the pantothenate available to
microorganisms.

Success was limited.

Acid or base hydrolysis

destroyed the vitamin, and enzymatic procedures were empirical without
knowledge of how pantothenate was bound in tissues.

A rational

enzymatic approach would require at least one enzyme for each bound
form of pantothenate.

With the discovery of CoA as a major source of

bound pantothenate, a rational approach became possible.
Enzymatic Liberation of Pantothenate
from Coenzyme A
Coenzyme A inactivation by either intestinal phosphatase or an
extract of pigeon liver led to the use of these two preparations in
the enzymatic liberation of pantothenate from CoA (Novelli et al.
1949).

Inactivation by intestinal phosphatase was accompanied by a

complete liberation of organically bound phosphate.

However,

inactivation by the pigeon liver extract did not release phosphate and
was not inhibited by fluoride (an inhibitor of phosphatase).

The

pigeon liver extract was later found to function by releasing
cysteamine at the other end of the molecule (Fig. 1).

Both

preparations were necessary to release pantothenate from CoA because
pantothenate was bound by two distinct linkages.

Microbiological

assay of the pantothenate content of CoA correlated well with the
bioassay after this "dual enzyme'' treatment.

13

The Amidase in Pantothenate
Liberation
All known forms of pantothenate coenzymes function through the
thiol group of cysteamine.
pantothenate.

Cysteamine is attached by amide bonding to

Liberation of bound pantothenate prior to assay

therefore requires an amidase to split this bond.

As pantothenate

also contains an internal amide bond, the problem is not trivial, and
enzymatic methods are usually employed.

Optimal characteristics for

this amidase are listed below and are covered in the following
paragraphs:
1)

Readily obtainable source

2)

Low pantothenate content

3)

High stability

4)

Quantifiable activity

5)

Determined specificity

Only preparations commonly used to liberate pantothenate from
biological samples will be covered in this section.

These amidase

sources were developed from 1945-1955 and are still used today in
"total" pantothenate determinations.

Current research on the

enzymatic hydrolysis of pantetheine to pantothenate and cysteamine,
which is concerned with the metabolic implications of the reaction
rather than its practical significance in pantothenate assay, will be
covered in Chapter II.
Source.

The original source of the amidase was an extract of an

acetone powder of pigeon liver (Kaplan and Lipmann 1948).

Neilands

and Strong (1948) described a preparation at least as effective from

14

the more readily available chicken liver.

Rabbit, hog, and beef liver

were not good sources (Novelli et al. 1949), but hog, lamb, and rat
kidney were (Schweigert and Guthneck 1953; Novelli 1953).

In general,

avian liver or mammalian kidney appeared to be good sources.
Pantothenate content.

If the amidase is to be used to liberate

and determine pantothenate, it should not contain much pantothenate
itself.

This "enzyme blank" limits the sensitivity of the

determination.

Neilands and Strong (1948) suggested purifying the

enzyme to remove high pantothenate levels, and Novelli et al. (1949)
unsuccessfully tried ammonium sulfate fractionation.
The problem was at least partially solved by Novelli and Schmetz
(1951) who used an anion exchange resin to bind pantothenate

containing anions in the extract.

Many investigators have since used

resin treated liver extracts with apparent success for "total"
pantothenate determination (Zook et al. 1956; Slepyan et al. 1957;
Ishiguro et al. 1961; Barton-Wright and Elliott 1963; Nakamura et al.
1967; Cohenour and Calloway 1972).

However, others do not find the

pantothenate blanks of the resin treated extracts as satisfactory.
Clegg (1958) reports troublesome growth stimulation from the extract
and Hatano (1962) uses only half as much enzyme to reduce blank
values.

Markkanen (1973) cites the unavailability of the en1yme, "in

a sufficiently high grade of purity" (p. 313), as a possible
explanation for the wide variation in reported pantothenate levels in
blood (Pearson 1980).
unreliable and use

11

Baker and Frank (1968) find use of the amidase

Clarase

content, for liberation.

11
,

an amylase· with low pantothenate

15

Stability.

Kaplan and Lipmann (1948) first noticed the lability

of the CoA inactivating enzyme from pigeon liver.

Although claimed

stable when frozen, standing for 4 hours at room temperature, or
dialyzing 24 hours at 5°C destroyed most, if not all, of the activity
(Novelli et al. 1949).

Jannes (1950) could not prepare the amidase

from pigeon or chicken liver, stating, "the work proved to present
many technical difficulties.

The enzyme produced ... proved to be

very labile, and the possibilities of storing it were quite poor" (p.
60).
Activity measurement.

The American Association of Agricultural

Chemists abandoned its four year study to develop a standard assay for
total pantothenate because of difficulty with the amidase preparation,
stating:
Results using pigeon liver or hog kidney enzyme
preparations were similar. However, a loss of
activity of these enzyme preparations showed a need
for establishing the activity of the enzymes before
they could be relied upon for use in the assay
procedure (Toepfer 1960, p. 29).
The report is concluded by suggesting that, "when sufficient
information on the specific enzyme activity is available, it may be
desirable to reactivate collaborat i ve studies" (p. 29).

Markkanen

(1973), also concerned about the activity of the amidase, states that,
"the various enzyme preparations may have differed decisively in
aCt i V ity II

(

P, 313 ) ,

The amidase activity in preparations used for total pantothenate
assay has never been quantified.
maximal liberation.

"Enough" enzyme is added to give

Novelli (1955) suggests "titration" of the pigeon
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liver enzyme to produce maximal liberation and then using double the
amount for routine assay.

Exact quantitation of the amount of

activity required in terms of a specific substrate would be preferable
and allow comparison between different preparations and laboratories.
Specificity.

The specificity of the various amidase preparations

used in total pantothenate assay is unknown.

Novelli et al. (1954)

do mention indications that avian liver enzymes prefer CoA as
substrate, while hog kidney preparations act primarily on pantetheine.
However, no experimental results are given.

Known specificity of the

amidase would determine whether the order of addition of phosphatase
and amidase is important in total pantothenate determinations.

It

would also help define the meaning of "total" pantothenate
measurements.
Total Pantothenate Assay
Most investigators studying pantothenate levels in tissues use
the dual enzyme system of amidase and phosphatase to determine "total"
pantothenate.

This conventional dual enzyme system was designed to

liberate pantothenate from CoA and its use in tissue determinations is
an extrapolation.

The assumption is that bound pantothenate is

present in tissues as CoA or other bound forms of the vitamin that are
liberated by the dual enzymes.

This assumption is wrong.

In the acyl

carrier protein of fatty acid synthesis, phosphopantetheine is linked
to serine via a phosphodiester bond that is not hydrolyzed by the dual
enzymes (Majerus et al. 1965).

There may be other bound forms of

pantothenate that are not liberated, for example, various natural
glycosyl derivatives (Imamoto et al. 1979).

In a recent article
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reminiscent of early studies, "substantially and consistently higher
values of pantothenate" (p. 131), were found by chick assay than by
microbiological assay with prior dual enzyme treatment (Latymer and
Coates 1982).

Apparently, significant amounts of bound pantothenate

are not hydrolyzed by the dual enzymes.
Significance and Objectives of the Study
Assay
Available enzyme assays for the hydrolysis of pantetheine to
pantothenate and cysteamine are either lengthy or require special
equipment (see Chapter II).

Simple assays would expedite purification

of the enzyme as well as allow quantitation of amidase activity from
different sources.
Purification
A stable purified source of the amidase with low pantothenate
content would be useful in routine pantothenate assay.

The enzyme has

never been purified for use in pantothenate assay, and homogeneous
preparations from horse kidney could not be prepared "routinely"
(Dupre and Cavallini 1979, p. 266).

A reliable homogeneous

preparation would allow detailed characterization.
Characterization
Certain characteristics of the amidase, such as its pH profile
and substrate specificity, are important for the liberation of
pantothenate from biological sources.

Other characteristics,

including subcellular localization, apparent K , molecular weight,
m
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amino acid analysis, and carbohydrate analysis may help to clarify
this enzyme's place in the metabolism and regulation of CoA levels.
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CHAPTER II
REVIEW OF LITERATURE
Review of the significance of pantetheine hydrolysis in coenzyme
A metabolism and in the liberation of pantothenate for assay is
covered in Chapter I.

This chapter deals with the work of three

contemporary research groups interested in the enzymatic hydrolysis of
pantetheine.

Dupre and Cavallini (1979), based in Italy, have been

interested in pantetheine hydrolysis as a source of cysteamine for
taurine biosynthesis.

Abiko (1975) of Japan has studied the

hydrolysis of pantetheine as part of the metabolism of coenzyme A.
Finally, Orloff et al. (1981), of the United States have looked at
altered pantetheine hydrolysis as a possible mechanism of cystine
accumulation in cystinosis. ·

The liberation of pantothenate was originally monitored
microbiologically, a method used recently by Abiko (1975) after ion
exchange separation of pantothenate.

The tedium of the procedure has

led to the development of other assays.

.

Cavallini et al. (1964)

measured the hydrolysis of pantethine by coupling the production of
cystamine to its oxidation with amine oxidase and measuring the uptake
of oxygen.

When reducing compounds were found to activate the

reaction (Cavallini et al. 1968), other methods were developed.

These

included assays based on the chromatographic (Cavallini et al. 1968)
and electrophoretic (Dupre et al. 1970a) separation of 14 c-labeled
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substrate and product.
assay,

11

Orloff et al. (1981) found the microbiological

time consuming and erratic ... whereas the radiochemical assay

required an expensive radiolabeled substrate that must be specially
synthesized

11

(p. 1063). The fastest procedure available was still

limited by a 5-hour electrophoresis step.
Recently, methods with a fast turnaround have been developed.

A

pH-stat procedure was reported by Dupre et al. (1976), and Orloff et
al. (1981) have measured hydrolysis through amino acid analysis of the
N-ethylmaleimide adduct of cysteamine.

These procedures do however

require special equipment.
Current assays all employ a thiol reducing compound as an
activator, and an incubation temperature around 37°C (Table 2).
However, the substrate concentration used varies widely and its exact
form is often vague or unspecified.

The racemic substrate is used by

Dupre et al. (1970a), but Abiko (1975) and Orloff et al. (1981) do not
specify whether they used the racemic compound or the biologically
active (D) stereoisomer.
The reduction state of the substrate is often unclear.

Dupre et

al. (1970a) add 5 mM DL-pantethine and 15 mM cysteine simultaneously
into the reaction mixture at the start of the incubation period.

An

equilibrium mixture of pantetheine and pantethine results as
thiol-disulfide exchange occurs.

Their product vs. time curve shows

an initial lag period before linearity is established.

Alternative

explanations include insufficient enzyme activation by cysteine or
preference of the enzyme for pantetheine· over pantethine as a
substrate.

Dithiothreitol quantitatively reduces disulfides

Table 2.

Literature Assay Conditions.

Reference

Buffer

Activators

Substrate

Miscellaneous

Dupre et al. 1970a

0.05 M phosphate
pH 7.6

15 mM cysteine

5 mM DL-pantethine

60 min at 38°C

Abiko 1975

0.08 Mtris-maleate
pH 7.0

20 mM cysteine

0.1 mM pantetheine

30 min at 37°C

6.6 mM 0-pantetheine

37°C

6.6 mM pantetheine

38°C

Dupre et al. 1976

(pH-stat)

134 mM OTT*

Dupre and Cavallini 1979

(pH-stat)

14 mM OTT*

Orloff et al. 1981

0.05 M phosrhate
pH 7.6

0.4 mM OTT*
1 mM EDTA

0.8 mM pantetheine

90-240 min at 37°C

*Calculated as the amount of reduced OTT (dithiothreitol) remaining after substrate reduction.
N
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(Cleland 1964).

Although it is not clear Dupre and coworkers allowed

sufficient time in their pH-stat assay for complete pantethine
reduction before substrate addition to the enzyme, Orloff et al.
(1981) do specify a 10 minute preincubation at 37°C.
Purification
Initial attempts to purify the amidase from avian liver were
mentioned in Chapter I.

Partial success has recently been achieved

with mammalian kidney as an enzyme source.

Abiko (1975) solubilized

the enzyme from rat kidney microsomes with 0.5 % Triton X-100 in the
presence of 0.1 mM cysteamine.

Repeated gel filtration on Sephadex

G-200 resulted in a 75-fold purification with respect to the
homogenate.

A 2-fold purification of the enzyme found in the 100,000

g supernatant of rat kidney homogenates was also achieved by a 25-50%
(NH 4 )2so 4 fractionation.
Dupre et al. (1970b) reported a 3300-fold partial purification of
the enzyme from horse kidney in 11 %yield.

Purification steps

included homogenization of the frozen-thawed tissue, heating at 60°C
(pH 7.0) for 10 minutes, fractionation with (NH ) so (45-65%
4 2 4
saturation), CM-cellulose chromatography (pH 5.0), DEAE-cellulose
chromatography (pH 7.6), and zone electrophoresis at pH 6.0 on a
cellulose column.

The highest specific activity obtained from

selected fractions of the cellulose column was 70-100 nmoles of
pantothenate produced per minute per mg of protein.

Gel

electrophoresis showed the presence of three main components.
Complete purification was claimed in an abstract from the Ninth
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International Congress of Biochemistry (Dupre et al. 1973a).
Homogeneity on ultracentrifugation and disc-electrophoresis, a
molecular weight of 55,000, and an amino acid composition were
apparently presented, although no specific data are recorded.

Details

of a modified purification have been reported by Dupre and Cavallini
(1979).

Although the final step could not be done

11

routinely 11 (p.

266), a 16,000-fold purification with 12.8 % yield gave a preparation
claimed to be homogenous on ultracentrifugation and disc
electrophoresis.
presented.

No experimental evidence for homogeneity was

Purification steps included homogenization, heating at pH

5.5 in a boiling water bath up to 55°C, fractionation with (NH ) so
4 2 4
and ion exchange chromatography as in the original procedure, gel
filtration on Sephadex G-200, and recycling on Sephadex G-75.

The

highest specific activity obtained was 400 nmoles of pantothenate
produced per minute per mg of protein.
Reported specific activities are difficult to compare.

Not only

do the enzyme assays differ, but protein determinations vary between,
and sometimes within, a purification.
his method of protein assay.

Abiko (1975) does not specify

Dupre et al. (1970b) calculated the

protein concentration of the starting homogenate by the dry weight of
samples kept at 110°C to constant weight.

Protein in the other

fractions, as well as in the modified purification scheme (Dupre and
Cavallini, 1979) was determined by the biuret reaction with bovine
serum albumin as standard (Gornall et al. 1949).
Reported homogenate specific activities from various sources are
presented in Table 3.

Dupre et al. (1970a) present data for assay
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Table 3.

Homogenate Specific Activities.

Reference

Source

Protein Assay

Specific
Activity*

Dupre et al. 1970a

horse kidney

Gornall et al. 1949

0.42

Dupre et al. 1970b

horse kidney

dry weight at 110°C

0.017

Dupre and Cavallini
1979

horse kidney

Gornall et al. 1949

0.025

Abiko 1975

rat kidney

unspecified

0.25

rat liver
Orloff et al. 1981

human WBC

0.076
Lowry et al. 1951

human
fibroblasts

0.87
0.040

*Given as nmoles of pantothenate liberated per minute per mg of
protein.
validation indicating a horse kidney homogenate specific activity of
0.42 nmol pantothenate/min/mg, yet in their purification schemes, they
list 0.017 (Dupre et al. 1970b) and 0.025 nmol/min/mg (Dupre and
Cavallini, 1979).

A low homogenate specific activity would give a

high apparent degree of purification.
Characterization
Sources
In addition to the enzyme sources given in Table 3, the enzymatic
hydrolysis of pantethine has been demonstrated in homogenates of
liver, kidney, heart, and muscle of horses, cattle, pigs, and rats
(Cavallini et al. 1964).

However, the absence of activating thiol
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compounds in the amine oxidase coupled assay makes quantitative
comparisons with more recent assays difficult.

Horse and cattle

kidneys contain about the same amount of enzyme, whereas pig kidney
shows an activity about three times as high (Dupre et al. 1970b).
Intracellular Location
In rat liver, pantetheine splitting activity is exclusively
located in the microsomal-lysosomal fraction, whereas it distributes
to both the soluble and microsomal-lysosomal fractions in rat kidney
(Abiko, 1975).

The intracellular location of the enzyme purified from

horse kidney (Dupre and Cavallini, 1979) has not been studied.
Michaelis Constant and pH Optimum
Available Michaelis constants and pH optima for the enzyme from
various sources are given in Table 4.

A neutral to acidic pH optimum

is observed, depending on the source.

Reported Km values vary over a

100-fold range.
Substrate Specificity
All relevant studies show a high degree of substrate specificity
for D-pantetheine.

Dupre et al. (1970b) showed by amino acid analysis

of e-alanine that aletheine (<1%) and pantothenate (ca. 2%) are poor
substrates relative to pantetheine.

Pantothenoyl-L-cysteine,

4'-phosphopantothenoyl-L-cysteine, pantetheine thiazoline, and CoA
were hydrolyzed very slowly if at all (Dupre et al. 1973b; Abiko
1975).

L-pantetheine was apparently hydrolyzed at a rate less than 2%

of D-pantetheine (Bellussi et al. 1974).

However, these results are
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Table 4.

Literature Michaelis Constants and pH Optima.

Reference

Km

pH Optimum

Source

(pantetheine)
Dupre et a 1. 1970b

horse kidney

4.0-5.5

10 mM DL

Dupre et al. 1976

3 mM D

Dupre and Cava 11 i ni
1979

5 mM

Abiko 1975

rat kidney supernatant

7.5

0.031 mM

rat kidney microsomes

7.0

0.036 mM

6

0.095 mM

6.5-7.5

0.44 mM

6-7

0.11 mM

rat liver
Orloff et al. 1981

human WBC
human fibroblasts

questionable as L-pantetheine was obtained by exhastive enzyme
hydrolysis of DL-pantetheine.
Dupre et al. (1973b) found 4'-phosphopantetheine to be hydrolyzed
at 10% the rate of pantetheine.

The presence of contaminating

alkaline phosphatase activity and an incubation of 3 hours make prior
hydrolysis of the phosphate a possibility.

The enzyme from rat liver

cannot hydrolyze 4'-phosphopantetheine at all if 1 mM sodium fluoride
(an inhibitor of pho?phatase) is included in the incubation mixture
( Ab i ko , 19 75 ) .
Dupre et al. (1973b) concluded that the real substrate for the
enzyme from horse kidney, previously called pantethinase, was
pantetheine, the reduced form of pantethine.

However from their data

it is impossible to separate the preference of the enzyme for
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the reduced substrate from the thiol activating properties of
pantetheine.

The enzyme is apparently a thiol protease (Dupre et al.

1973a) and disulfide exchange with the active site may be the sole
reason for decreased activity with pantethine.
Activators and Inhibitors
The activation by thiol compounds has already been mentioned.
This activation is not specific; mercaptoethanol and dithiothreitol
give the highest effect (Dupre et al. 1970b).

Iodoacetate and

iodoacetamide are inhibitors at high concentrations when preincubated
with the enzyme and the excess is removed by dialysis before activity
determination (Dupre and Cavallini, 1979).

Fifteen millimolar sodium

azide inhibits 90%.
Inhibition by the products of the reaction, pantothenate and
cysteamine, has been observed.
60% (Dupre et al. 1970b).

Fifty millimolar pantothenate inhibits

Inhibition by cysteamine has been reported

as 10% with 50 mM cysteamine (Dupre et al. 1970b) and 44% with 5 mM
cysteamine (Dupre and Cavallini, 1979).
Stability
The enzyme from horse kidney is stable indefinitely when frozen at
neutral pH or lypholyzed in the absence of salts (Dupre et al. 1970b).
Dilute solutions at 0°C lose activity at about 5% per week.

The

stability is good between pH 5.0 and pH 7.6, but rapidly decreases
outside these limits (Dupre and Cavallini, 1979).
Other Properties
A molecular weight of 55,000 has been obtained by ultra-
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centrifugation.

The enzyme has an isoelectric point of 4.8 and an

extinction coefficient determined by amino acid analysis of

E~~m (280 nm)=15.2 (Dupre and Cavallini, 1979). Evidence for these
properties was apparently presented at the Ninth International
Congress of Biochemistry (Dupre et al. 1973a), but only an abstract
survives.
Summary
The enzymatic hydrolysis of pantetheine to pantothenic acid and
cysteamine has been previously studied.

Quantitative assays have been

developed, a complete purification from horse kidney has been
reported, and many characteristics of the enzyme have been determined.
However, the assays are time consuming or require special equipment,
the purification is not performed "routinely" (Dupre and Cavallini,
1979, p. 266) and experimental evidence for homogeneity is lacking.
Different authors report widely different Km values and pH optima.
Attempts in our laboratory to repeat the published purification from
horse kidney have been unsuccessful (Chapter III).
not been reported.

Its repetition has
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CHAPTER III
MATERIALS AND METHODS
The objectives of this study include development of rapid and
reliable assays, routine purification to homogeneity, and
characterization of a pantetheine hydrolyzing enzyme.
Preliminary Studies
Initial studies with horse kidney were performed in order to
replicate the extensive work of Dupre and coworkers (Chapter II).

The

time and labor required for the radiolabeled assay (Dupre et al.
l970a) led to the development of a simpler radiolabeled assay reported
later in this chapter.

Use of this modified assay and estimation of

protein by the method of Lowry et al. (1951) gave a specific activity
for horse kidney homogenates of 0.8-1.4 nmols of pantothenate produced
per min per mg of protein.

This is close to the value of 0.42

nmoles/min/mg calculated from data given by Dupre et al. (1970a).

Pig

kidney homogenates gave higher specific activities (l.8-3.2
nmol/min/mg), similar to the 3-fold increase reported by Dupre et al.
(1970b).
Purification according to Dupre et al. (1970b) was begun.

The

first step (heat treatment) is reported to give a 9-fold purification
in 87.5% yield.

However, in our laboratory no increase in specific

activity and a loss of about two thirds of the total activity was
Similarly, (NH )2so 4 fractionation on the heat
4
treated enzyme (the second step) resulted in loss of activity without
repeatably found.
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significant gain in specific activity.

Inability to repeat the

published purification led to the eventual development of an
independent scheme.

As pig kidney was a richer source of the enzyme

and more readily available than horse kidney, it was used as the
enzyme source.

Four rapid, independent assays of enzymatic pantetheine
hydrolysis were developed.
hydrolysis products:

Two assays detected specifically the

cysteamine was measured by the absorbance of its

fluoropyruvate adduct at 300 nm and pantothenate was measured by
radioimmunoassay. Methods of [ 14 cJ pantethine synthesis were reviewed
and the labeled substrate employed in a third enzymatic assay.

A
1

fourth assay continuously monitored the absorbance of mercaptide ions
at 240 nm.

The mercaptide ion concentration increased proportionally

with hydrolysis at a buffered pH because of a difference in pK(-SH)
between pantetheine (9.9) and cysteamine (8. 1) at 37°C.
Materials
The sodium salt of fluoropyruvic acid, dithiothreitol,
dithioerythritol, cysteamine diHCl, 1-hydroxybenzotriazole, and Tris
(Tri~ma

Base) were obtained from Sigma (St. Louis, Mo.).

0-Pantethine

and 0-calcium pantothenate were from U.S. Biochemical (Cleveland,
Ohio) and DL-calcium pantothenate from ICN Pharmaceuticals (Cleveland,
Ohio).

Dicyclohexylcarbodiimide and

(Milwaukee, Wisc.).

cys~eamine

HCl were from Aldrich

The sodium salt of O-[l- 14 c] pantothenic acid,
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ca. 50 mCi/mmol was supplied by New England Nuclear (Boston, Mass.).
Other chemicals were analytical or scintillation grade.

Sephadex

G-25, 50-150 µm, was from Pharmacia (Piscataway, N.J.) and type BA85
nitrocellulose filters (25 mm) were from Schleicher and Schuell
(Keene, N.H.).

A glass calomel combination electrode (Sigma) was used

for pH measurements.

Absorbance was determined on a Gilford Model 240

spectrophotometer with silica cuvettes of 1-cm light path.
Substrate Preparation
O-[l- 14 c] pantethine was synthesized by direct condensation of
the salts of O-[l- 14 cJ pantothenic acid and cystamine by the
1-hydroxybenzotriazole dicyclohexylcarbodiimide method of Konig and
Geiger (1970) .

OL-pantethine was similarly prepared.

The application

of this method to pantethine synthesis and the purification of
pantethine have been the subject of numerous recent patents which can
be consulted for details. 1 The concentration of pantethine in
solution was standardized by disulfide analysis (Zahler and Cleland,
1968).
0-Pantethine was reduced to 0-pantetheine by the method of Butler
et al. (1976) for the reduction of disulfide-containing amines.
partition

coeffici~nts

The

(H 20/ethyl acetate) of pantetheine and

dithiothreitol were ca. 9 and 0.5, respectively.

Pantetheine

1
The first of several Japanese patents to appear was Japan. Kokai 76,
113,821 October 7, 1976, 8 pp. (Chemical Abstracts 86:171840d). A
version in English exists: Brit. 1,561 ·,047 February 13, 1980, 4 pp.
(Chemical Abstracts 93:47198f).

solutions were stored under nitrogen and standardized by sulfhydryl
analysis (Ellman, 1959).
Enzyme Preparation
Enzyme taken after (NH 4 )2so fractionation (see this chapter
4
11
11
under, Purification ) and desalted through Sephadex G-25 into 0.02 M
phosphate, pH 7.0 was used in validating the enzyme assays. · This
preparation had an activity of 0.50 µmoles of pantothenate
produced/min/ml by the radiolabeled assay presented below and will be
referred to hereafter as the

11

(NH 4 )2so 4 enzyme solution. 11

Radiolabeled Assay
Both substrate and enzyme were reduced before assay.
14
D-[ c] pante~hine (60 µCi/mmol) was reduced to D-[ 14 cJ pantetheine by
preincubating 12.5 mM pantethine with 25 mM dithioerythritol for 20
min or more at 37°C in 0.05 M Tris-HCl, pH 8.1.

The enzyme was

preincubated at 37°C for 20 min with 10 mM dithioerythritol in 0.05 M
Tris-HCl, pH 8.1.

The assay was initiated by adding 20 µl of

prereduced substrate solution to 80 µl of prereduced enzyme solution.
The reaction was stopped after 15 min at 37°C by the addition of
200 µl of acetone.

After centrifugation, the supernatant was spotted

near one end of a 20 cm strip of Whatman No. 4 filter paper (2.5 cm in
width).

Spotting was done quickly over a 2- to 3-cm area with a

hot-air dryer.

The paper was chromatographed (ascending) with

acetone/H 2o (90/10) in a small chromatography jar (6 X 10 X 15 cm)
open to the atmosphere.

The solvent traveled quickly up the paper,

then slowed and stopped from evaporation.

Under these conditions,
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pantetheine moved with the solvent front and pantothenate remained
where spotted.

After 15 min the filter paper was removed and dried.

The distribution of radioactivity was determined qualitatively by
gas-flow radiochromatoscanning (Actigraph III, Nuclear Chicago, 6 mm
slit width), or quantitatively by liquid scintillation counting.

For

quantitation, the dried strip was cut halfway between the origin and
front.

Each half was placed in a separate scintillation vial,
toluene/PPO/POPOP 2 (1 liter/4 g/50 mg) added to cover the strip, and
each vial counted to 10,000 total counts in a Packard 3255 liquid
scintillation spectrometer.
Blanks were run without enzyme and with excess enzyme to
determine the separation limits achieved under conditions of 0 and
100% hydrolysis.

Under 1%, and over 90%, respect1vely, of the counts

were found in the origin half of the strip.

Linearity was

demonstrated by using various proportions of labeled pantothenate and
labeled pantethine without active enzyme present.
Pantothenate Assay
Substrate and enzyme preincubation were the same as in the
radiolabeled assay except that 5 mM 0-pantethine was reduced with 10
mM dithioerythritol for 20 min or more at 37°C in 0.05 M Tris-HCl, pH
8.1.
~l

Ten microliters of prereduced substrate solution was added to 90

of prereduced enzyme solution to start the assay.

2Abbreviations used: PPO, 2,5-diphenyloxazole; POPOP,
l,4-bis(5-phenyloxazol-2-yl)benzene.
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The reaction was stopped after 15 min at 37°C by the addition of
100 µl of 0.3 N Ba(OH) , followed by an equivalent amount (Somogyi,
2
1945) of ZnS0 4 , and H o to 1.0 ml. After centrifugation, the
2
supernatant was analyzed for pantothenate by the radioimmunoassay of
Wyse et al. (1979), modified to use nitrocellulose filters in the
separation of antibody-bound and free hapten as follows.

Unknown or

standard was added, in a volume of 500 µl, to 500 µl of the antisera
dilution (made without added rabbit albumin) containing 10,000 dpm of
D-[l- 14 c] pantothenate instead of D-[3- 3H] pantothenate. After l min
or more at room temperature, the sample was cooled on ice and evenly
vacuum filtered through a prewetted nitrocellulose filter into a
scintillation vial.

A Gelman No. 4204 filter funnel (Ann Arbor,

Mich.) mounted on a cork, with vacuum introduced through a hypodermic
needle was found convenient.

The filter was immediately washed with

500 µl of ice-cold 10 mM phosphate, pH 7.0, containing 140 mM NaCl.
The vacuum was released by lifting the filter (forcing the wash in the
stem into the vial) and the filter transferred to another
scintillation vial.

Appropriate scintillation cocktails were added

(Gershman et al., 1972) and both fractions radioassayed to determine
the percentage binding.
Cysteamine Assay
Substrate and enzyme preincubation were the same as in the
pantothenate assay.

Reaction was initiated by diluting 150 µl of

prereduced enzyme solution with 300 µl

of

0.05 M Tris-HCl, pH 8.1, and

adding 50 µl of prereduced substrate solution.
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The reaction was stopped after 15 min at 37°C by adding 50 µl of
50% trichloroacetic acid.

After centrifugation, the supernatant was

analyzed for cysteamine by a modification of the method of Herrington
et al. (1967) for aminoethanethiols in biologic media.

Five hundred

microliters of the supernatant was added to 1.5 ml of 0.8 M Tris-HCl,
pH 9.0, and warmed to 37 °C.

One milliliter of 0. 16 M fluoropyruvate

in 0.05 M EDTA (pH 5.5) at 37°C was added.

After 10 min at 37°C, the

absorbance was read at 300 nm.
Blanks without enzyme, but with pantethine or cystamine,
or reactions run to substrate exhaustion established a 6A 300 (ca.
0.78) corresponding to 100% hydrolysis. The equivalence of these
calibration methods demonstrated that oxidation of cysteamine was
not occurring.

The absorption of the pantethine blank against H20

wa~

ca. 0.35.
Mercaptide Assay
Enzyme preincubation was the same as in previous assays.

Three

hundred microliters of prereduced enzyme solution was diluted with
2.69 ml of 0.05 M Tris-HCl, pH 8.1, which had been deoxygenated by
bubbling N through the solution and warmed to 37°C. The A
was
2
240
followed for 10 min or until a constant decrease with time could be
determined.

Pantetheine was added (10 µl of 150 mM) to initiate the

reaction and the A240 followed. The maximal 6A 240 per minute (after
linearization and before product inhibition) was proportional to the
amount of enzyme present when the rate before substrate addition was
taken as baseline.

Blanks without enzyme, but with pantetheine or

cysteamine, or reactions run to substrate exhaustion established a
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6A240 (ca. 0.73) corresponding to 100% hydrolysis. The equivalence of
calibration methods again demonstrated that oxidation of cysteamine
was not occurring.

The absorption of the pantetheine blank against

H2o was ca. 0.60.
Purification
Fresh pig kidneys (Tri-Miller Packing, Hyrum, UT) were cooled on
ice and slices of cortex frozen until use.

Five hundred and fifty

grams of semi-solid, thawed (4°C, 8 hours) cortex were carried through
the purification.

Our equipment limited the scale of Steps l through

3 to ca. 275 grams of cortex.

Therefore, these steps were performed

twice per purification to provide a pooled extract from 550 grams of
cortex at the end of Step 3 that was used in the remaining
purification.
Step l:

All steps were performed at 0-4 °C unless indicated.

Homogenate

Two hundred and seventy-five grams of cortex were homogenized
with 4 volumes of 0.02 M Tris-HCl, pH 8.2 in a Waring blender for 4
min at high speed.

The suspension was centrifuged for 10 min at

10,000 g and the supernatant aspirated from pelleted large particulate
matter.
Step 2:

Microsomal Agglutination

Microsomes in the supernatant were agglutinated at pH 4.2 by the
addition of l M formic acid and centrifuged for 10 min at 20,000 g.
The supernatant was decanted and the pellet resuspended in ca. 400 ml
of deionized water by homogenization in a Waring blender at high speed
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for 20 sec.

The suspension was brought to pH 5.75 with 0.5 M

Tris-HCl, pH 9.0.
Step 3:

Butanol Solubilization

One and a half volumes of n-butanol was added to the microsomal
suspension and the mixture homogenized in a Waring blender at low
speed for 2 sec.
10,000 g.

The material was then centrifuged for 10 min at

The aqueous phase containing solubilized enzyme was

aspirated and immediately passed through a column (5.5 x 65 cm) of
Sephadex G-25 previously equilibrated with 0.02 M phosphate, pH 7.0 to
remove dissolved butanol.
Step 4:

Heat Treatment

The void volume eluate from Step 3 was brought to pH 5.0 with 1 M
formic acid and heated in a 75°C water bath up to 70°C and held at
70°C for 2 min.

The suspension was rapidly cooled, centrifuged for 10

min at 20,000 g, and the supernatant aspirated from coagulated
proteins.
Step 5:

(NH 4 )2so 4 Fractionation

The supernatant from Step 4 was saturated to 55% by adding 32.6 g
solid (NH 4 )2so 4 per 100 ml and then centrifuged for 15 min at 20,000
g. The resulting supernatant was saturated to 70% by adding 9.3 g
(NH 4 ) 2so 4 per 100 ml and then centrifuged for 30 min at 20,000 g.

The

precipitate was dissolved in ca. 20 ml of hydrophobic chromatography
application buffer 11 (114 g of (NH 4 )2so 4. added to 1 liter of 0.02 M
phosphate, pH 7.0).
11
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Step 6:

Hydrophobic Chromatography

The protein from Step 5 was applied to a 2.5 x 23 cm column of
Octyl-Sepharose CL-48 (Pharmacia) that had previously been
equilibrated with application buffer.

The protein was washed with

application buffer at a flow rate of ca. 150 ml/hour until the A280 of
the eluate was less than 0.05. Enzyme was eluted with a solution of
20% ethylene glycol, 80% application buffer (v/v) at the same flow
rate until the A
was less than 0.03. The column was regenerated by
280
sequentially applying one column volume each of 50 mM NaOH, 95%
ethanol, deionized H o, and application buffer.
2
Step 7: Hydroxyapatite
Chromatography
The enzyme eluate from Step 6 was concentrated to ca. 20 ml by
ultrafiltration and diafiltered into 0.001 M phosphate, pH 7.0 with an
Amicon PM 10 ultrafiltration membrane (Lexington, MA).

The solution

was applied at ca. 25 ml/hour to a 1.5 x 5 cm Bio Gel HT hydroxyapatite column (Bio Rad, Richmond, CA) previously equilibrated with
0.001 M phosphate, pH 7.0.

Enzyme was eluted at the same rate with

0.02 M phosphate, pH 7.0.
Characterization
Intracellular Distribution
Fresh pig kidney cortex was homogenized and fractionated by the
method of Ali and Lack (1965).

Glucose-6-phosphatase activity was

estimated by the method described by DeDuve et al. (1955) with
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inorganic phosphate determined by the method of Fiske and Subbarow
(1925).

Pantetheine hydrolyzing activity was measured by the

cysteamine assay and protein determined according to Lowry et al.
(1951).
Substrate Specificity
Analogs of D-pantetheine with modifications in the pantoyl (A
series), s-alanyl (B series), and cysteamine (C series) moieties were
tested for relative enzymatic hydrolysis with the cysteamine (A and
B series) and pantothenate (C series) assays.

The initial analog

concentration was equivalent to 1 mM D-pantetheine and analog
hydrolysis was compared to the hydrolysis of 1 mM D-pantetheine under
the same conditions.

Enzyme was properly diluted from Step 7 of the

purification to give values falling on the linear portion of the
relevant hydrolysis curve.
Analogs in the A and B series were often synthesized by lactone
fusion of a pantolact one analog and an aletheine analog by a method
similar to that of Barne t t (1944).

The acid salt of the aletheine

analog in dry methanol was titrated with sodium methoxide to the color
change of cresol red before addition of the lactone.

Analogs in the C

series were synthesized by the 1-hydroxybenzotriazole dicyclohexylcarbodiimide method of peptide synthesis of Konig and Geiger (1970),
following the synthesis of pantethine.
Cleanup of all neutral analogs consisted of:

a) ether extraction

(2 x 1 volume), b) passage through an excess of mixed bed ion exchange
resin (Amberlite MB-3, Sigma) at 5 ml/min/cm 2 , and if necessary, c)
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preparative thin layer chromatography (TLC) on Whatman PLK5 plates
(Clifton, N.J.) with methyl ethyl ketone saturated with water as
solvent.

All cleanup was performed at 0-5°C.

Purity of the analogs was demonstrated by analytical TLC on
Whatman MK6F plates with methyl ethyl ketone saturated with water as
solvent at 0-5°C using iodine vapor staining.

Structural verification

was by proton magnetic resonance spectroscopy.

A JEOL FX90Q Fourier

transform NMR spectrometer with proton resonance at 89.60 MHz was used
in the homonuclear gated decoupling mode to eliminate solvent
resonance.

Spectra were taken at ambient probe temperature (ca. 25°C)

in 5 mm diameter tubes containing a 100 mM solution of the analog in

o2o with

3-(trimethylsilyl)-tetradeuterosodium propionate (Wilmad,

Bµena, N.J.) as internal standard.

Specific rotations were determined

in a 20 cm tube at ca. 10 g/100 ml with methanol as solvent in a
Rudolph Model 63 polarimeter.
Analog AI:

N-acetylcysteamine.

N-Acetylcysteamine was purchased

from Vega Biochemicals (Tucson, Ariz.) and used without further
purification.
Analog AII:

s-alethine diHCl.

A modification of the method of

Snell and Whittle (1957) was used to prepare s-alethine diHCl.
Phthaloyl-s-alanine was synthesized by the method of Nefkens (1960).
The final recrystallization of s-alethine diHCl was by solution in a
minimal amount of water at 70°C followed by slow addition of an excess
of ethanol. m.p. 220-221°C (lit. 221-222°C).
Analog AIII:

CoA.

Coenzyme A was from P-L Biochemicals

(Milwaukee, Wisc.) and was used without further purification.
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Analog BI:

N,N'-bis[pantoyl] cystamine.

Lactone fusion of

0-pantolactone (Sigma) and cystamine diHCl gave the desired product
(Barnett, 1944).

The reaction mixture was purified by ether

extraction and mixed bed ion exchange.
(lit. 141-144°C)
Analog BI!:

Yield 46%. m.p. 140-143°C

Analytical TLC Rf= 0.50.
N,N'-bis[pantoylglycyl] cystamine.

Synthesis of

N,N'-bis[glycyl] cystamine essentially followed the procedure of
Kopelevich et al. (1979) for the synthesis of alethine.

Subsequently,

fusion with 0-pantolactone gave the desired product.
N-t-BOC-glycine was from Vega (Tucson, Ariz.).

The succinimide

ester of N-t-BOC-glycine required excess ether in the final
recrystallization to avoid oil formation.

Yield 28%. m.p.

164.5-165.5°C.
After conjugation of the activated and protected amino acid with
cystamine, the t-BOC group was removed from N,N'-bis[N-t-BOC-glycyl]
cystamine in ethyl acetate solution with excess HCl gas.

N,N'-bis

[glycyl] cystamine diHCl crystallized on formation and was filtered
and washed.

Yield 91 %. m.p. 110°C (decomposition).

Lactone fusion of 0-pantolactone and N,N'-bis[glycyl] cystamine
gave the desired product as a viscous oil after cleanup (ether
extraction, mixed bed ion exchange, and preparative TLC).

Yield 43%.

Analytical TLC Rf = 0.42.
Analog BIII:

N,N'-bis[pantoyl-y-aminobutyryl] cystamine.

Synthesis essentially followed that of analog BI!.

N-t-BOC-

y-aminobutyric acid was purchased from Vega Biochemicals (Tucson,
Ariz.)
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Recrystallization of the succinimide ester of N-t-BOCy-aminobutyric acid was done in isopropanol/ether (5/1).
93%.

Yield

m.p. 116-ll8°C.
The t-BOC group was removed from N,N'-bis[N-t-BOC-y-aminobutyryl]

cystamine in ethyl acetate solution with excess HCl gas.

N,N'-bis

[y-amino-butyryl] cystamine formed an oil which crystallized after two
days at 4°C.

The crude product was recrystallized from a minimal

amount of ethanol with an excess of added isopropanol/ether (5/1).
Yield 37%. m.p. 152-155°C.
Lactone fusion of 0-pantolactone and N,N'-bis[y-aminobutyryl]
cystamine gave the desired product as a viscous oil after cleanup
(ether extraction, mixed bed ion exchange, and preparative TLC).
Yield 58%.

Analytical TLC Rf= 0.19.

Analog ·cI:

pantothenyl-s-aminoethanol.

This analog was

synthesized from D-calcium pantothenate and s-aminoethanol (Aldrich,
Milwaukee, Wisc.) by carbodiimide coupling.

Cleanup by ether

extraction and mixed bed i on exchange gave the pure viscous oil.
Yield 91 %. Analytical TL C Rf= 0.17.
Analog CII:

S-ethyl pantetheine.

Synthesis by carbodiimide

coupling of 0-calcium pantothenate and S-ethyl cysteamine (Aldrich)
and cleanup by ether extraction and mixed bed ion exchange gave the
pure viscous oil.
Analog CIII:

Yield 93%. Analytical TLC Rf= 0.42.
N,N'-bis[pantothenyl]-1 ,6-diaminohexane.

This

analog was synthesized from 0-calcium pantothenate and 1,6-diaminohexane (Aldrich) by carbodiimide coupling.

Cleanup by ether

extraction and mixed bed ion exchange, and recrystallization
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from acetone gave the pure product.
(decomposition).

Yield 89%. m.p. 74-77°C

Analytical TLC Rf= 0. 17.

Polyacrylamide Gel Electrophoresis
Nondenaturing polyacrylamide gel electrophoresis was performed
after Brewer and Ashworth (1969) and sodium dodecylsulfate
polyacrylamide gel electrophoresis after Laemmli (1970).
3 or 6 mm diameter were 10% in acrylamide.

Tube gels of

Protein and carbohydrate

were stained by the method of Phillips (1981) using coomassie blue
R-250 and periodic acid-Schiff 1 s (PAS) reagent with 5 and 30 µg of
protein, respectively, applied per tube.
Localization of activity on polyacrylamide gels.

To stain for

enzyme activity, 3 mm gels were immediately stirred after
electrophoresis with 500 volumes of deionized water (3 times for 15
min each).

The gels were then bathed in 2 volumes of 5 mM pantetheine

containing 5 mM dithiothreitol and 250 µM cresol red.

The solution

surrounding the gels was kept red by adding 0.05 N NaOH as necessary.
In ca. 15 min at ambient temperature, bands of activity in the gels
turned yellow from local titration of the indicator.

An enzyme

activity of 100 nmoles of pantothenate produced/min was applied per
tube.
Gel scanning.

An ISCO UA-5 absorbance monitor with a model 1310

gel scanner and a 0.5 mm slit was used.

Coomassie blue and PAS stains

were monitored at 580 nm while the activity stain was monitored at 435
nm.

The linear transport rate was 30 cm/hour.
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Amino Acid Analysis
The amino acid composition was determined on a Beckman Model 120B
amino acid analyzer modified to employ a 60 cm column of Durrum DC-lA
resin (Palo Alto, Calif.) for single column analysis.

Enzyme was

hydrolyzed with 4N methanesulfonic acid after Simpson et al. (1976)
with subsequent conversion of cysteine and cystine residues to
S-sulfocysteine.

Serine, threonine, and half-cystine were determined

by linear extrapolation of values from 22, 48, and 72 hours of
hydrolysis to zero time.

Values for isoleucine and valine were the

average of data at 48 and 72 hours of hydrolysis.

Norleucine was used

as an internal standard and tryptophan was determined spectrophotometrical ly by the method of Beneze and Schmid (1957).
Carbohydrate Analysis
Hexoses by gas chromatography.

Hexoses were identified and their

quantities est i mated by gas chromatography (GC) of their alditol
acetates on a 150 cm x 2 mm column of 3% SP-2340 on 100/120
Supelcoport following the directions of the manufacturer (Supelco,
Bellefonte, Penn.).

Glycoprotein was hydrolyzed and carbohydrate

residues derivatized by the method of Yang and Hakomori (1971).

A

Varian Model 2740 gas chromatograph with flame ionization detection
and a nitrogen carrier gas rate of 40 ml/min was used.

Column

temperature was programmed at 2°C/min from 180°C to 240°C after a 6
min initial hold after injection.
width at half the peak he i ght.

Peaks were quantitated using their
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Quantitation.

Total neutral hexoses were determined by the

anthrone reaction after Roe (1955) with a mixture of mannose,
galactose, fucose, and glucose (in proportion to their relative
amounts as estimated by GC) as standard.

Sialic acid was determined

by the resorcinol reaction after Svennerholm (1957) with
N-acetylneuraminic acid as standard.

Fucose was determined by the

cysteine-sulfuric acid reaction (Dische and Shettles, 1948).
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CHAPTER IV
RESULTS
This chapter summarizes results validating the enzymatic assay,
purification, and characterization of a pantetheine hydrolyzing enzyme
from pig kidney.

Discussion of these results follows in Chapter V.

The effects of enzyme concentration and incubation time on assay
results are shown in Table 5 and Fig. 4, respectively.
independently calibrated:

Each assay is

the radiolabeled assay by disulfide

analysis of pantethine, the pantothenate assay by dry weight
of D-calcium pantothenate, and the cysteamine and mercaptide assays as
given on page 35.

Pantothenate is quantitatively released at

substrate exhaustion (Table 5) and each assay follows a nearly
identical time course (Fig. 4).
The apparent activities of the homogenate and the (NH 4 ) 2so 4 enzyme
solution, along with coefficients of variation for the assays, are
given in Table 6.

A comparison with the enzyme assay of Dupre et al.

(1970a) is also included.
A typical 15 min chromotographic separation of pantethine and
pantothenic acid as used in the radiolabeled assay is shown in Fig. 5.
Substrate and product are well separated with pantethine concentrated
at the solvent front.
The effects of dithioerythritol and· enzyme prereduction on the
mercaptide assay are shown in Fig. 6.

Prereduction with
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Table 5. The Effect of Enzyme Concentration on Four Independent
Assaysa.
Radiolabeled . Pantothenate
5.0
[Pantetheine] (mM)
[Dithioerythritol] (mM) 13
[Enzyme] (%)b

Hydrolysis (%)

Cysteamine Mercaptide

1.0
10

1.0
4.0

0.50
1.0

nmolc

A300d

t:.A240/min

0.07
0.09

0.005
0. 01
0.02
0.05

0. 16

0.0004
0.0007
0 .0014
0.0034

0.36
0.84
1.6
3.8

0. 1

0.2
0.5

7.9
17

1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10 . 0

15

15
20
25
30
35
40

21
27
35
39
44
49

50

60

40

7.5

71

0.075
0. 15
0.21
0.29
0.35
0.41
0.48
0.55
0.59
0.63

0 .0072
0.014
0.022
0.029
0.038
0.044
0.051
0.056

97

100

aSee Chapter II I f or assay details. Approximate linear ranges are
between horizontal rulings in each column.
b

Percent volume of enzyme assay incubation mixture that was (NH ) 2so 4
4
enzyme solution.

cnmol pantothe nat e/1 00 µl enzyme assay.
dPantethine blank has been subtracted.
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Figure 4.

Time course of the enzymatic hydrolysis of pantetheine
monitored by four independent assays. In all assays,
prereduced enzyme was diluted and the reaction initiated as
in the mercaptide assay. The concentration of (NH ) SO
enzyme solution was 5% of the assay volume, and th~ ~niiial
concentration of D-pantetheine was 1.0 mM. The
concentration of dithioerythritol was 1.0 mM, except in the
cysteamine assay where it was increased to 4.0 mM to insure
complete reduction of cysteamine during analysis. Details
of analysis and calibration can be found in Chapter III.
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Table 6. Apparent Enzyme Activities and Coefficients of Variation.

Homogenate a
Activityc

Assay

(NH 4 )2so 4 Enzyme Solution b
Activityd

Coefficient of Variation(%)
(µmol/min/ml) (µmol/min/ml) Intra-assaye Inter-assay f

Radiolabeled

0.060

0.50

2.0

2.5

Pantothenate

0.058

0.60

6. l

10.4

Cysteamine

0.068

0.65

3.7

5.8

0.64

1.6

3.2

Mercaptide
Dupre et a 1.
(l970a)g

0.051

0.40

aSee Chapter III for preparation. The protein concentration was 33
mg/ml by the method of Lowry et al. (1951), and 41 mg/m1 by the
biuret reaction (Gornall et al. 1949) as used by Dupre and Cavallini
(1979). Bovine serum albumin was used as a standard.
bThe protein concentration was 1.3 mg/ml as measured by either the
method of Lowry et al. (1951) or the biuret reaction (Gornall et al.
1949). The (NH ) SO enzyme solution was ca. 150-fold purified with
respect to the it~rdng homogenate v1ith a total recovery of ca. 37 %.
cValues are the average of two determinations. The units
11
µmol/min/ml 11 refer to µmoles of pantothenate released per min per ml
of homogenate.
dValues are means of the 7 inter-assay samples, except for the assay
of Dupre et al. (l970a), which is the average of two determinations.

f

n=7

gThe substrate used was 2.5 mM 0-pantethine instead of 5.0 mM
DL-pantethine.
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Radiochromatographic scan of the separation between
pantethine and pantothenic acid achieved in the
radiolabeled assay. Pantetheine was concentrated at the
solvent front and pantothenate remained where spotted. For
details of the chromatographic separation and its analysis,
see page 32.
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The effects of dithioerythritol and enzyme prereduction on the mercaptide assay.
Incubation mixtures contained 1.0 mM D-pantetheine, 1% (NH ) 7S0 4 enzyme solution, and
0.05 M Tris-HCl, pH 8.1, with or without dithioerythritol 4pr~incubation as indicated.
Enzyme prereduction was with 1.0 mM dithioerythritol at 37°C. Each tracing has the
corresponding blank without enzyme subtracted.
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dithioerythritol is necessary for valid initial velocities.

When

pantetheine and dithioerythritol are added simultaneously, the
hydrolysis rate increases with time as the enzyme is activated by
reduction.

When dithioerythritol is not added, the initial rate is

the same as when the activator is added simultaneously with substrate.
With time, however, the A240 decreases when dithioerythritol is
omitted, and cysteamine oxidation invalidates the assay.
Purification
The purification of an enzyme from pig kidney hydrolyzing
pantetheine to pantothenate and cysteamine is summarized in Table 7.
A 5600-fold purification is obtained in 22% yield.

The purification,

including all assays and calculations can be done in less than 19
hours by one researcher.
Optimization of Individual Steps
In developing the purification scheme, each step was optimized for
critical variables using enzyme from the preceeding step.
Microsomal agglutination.

The recovery of enzyme activity

(radiolabeled assay) and protein (Lowry et al., 1951) on agglutination
of microsomes at pH's between 3 and 6 is shown in Fig. 7.

A pH of 4.2

was chosen as giving high total and specific activities.
Butanol solubilization.

The recovery of enzyme activity

(mercaptide assay) and protein (A 280 ) depends on the pH of the butanol
solubilization (Fig. 8 ). An optimal pH of 5.75 was routinely used.

Table 7.

Step

Purification of a Pantetheine Hydrolyzing Enzyme from Pig Kidney.

Fraction

Volume(ml)

Activity(µmol/min)a

Protein(mg)b

Specific Activity
(µmol/min/mg)

Homogenate

2700

250

99,000

0.0025

2

Microsomal
Agglutination

1100

170

43,000

0.0040

3

Butanol
Solubil ization

990

150

3,900

0.038

4

Heat Treatment

990

130

l ,400

0.093

20

92

260

0.35

15

4.5

5

(NH ) SO

Fra~tionation

6

Hydrophobic
Chromatography

160

68

7

Hydroxyapatite
Chromatography

23

56

4.0

14

aExpressed in terms of the mercaptide assay in µmoles of pantothenate liberated per minute. Steps l and 2
were measured by the radiolabeled assay and corrected for the difference between the radiolabeled and
mercaptide assays. This difference was obtained by measuring later steps with both assays.
b

Protein in steps
(280) = 11.3.

and 2 was measured by the method of Lowry et al. (1951).

Later steps used an E13
lcm
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5

pH

4

3

Optimization of microsomal agglutination. The microsomal suspension from Step l of the
purification (page 36) was agglutinated at a pH between 3 and 6 by the addition of formic
acid and centrifuged for 10 min at 20,000 g. The pellet contained various amounts of
enzyme activity and protein. Points shown are the average of triplicate determinations.
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Optimization of butanol solubilization. Microsomes
agglutinated at pH 4.2 from Step 2 of the purification
(page 36) were resuspended in deionized water by
homogenization and aliquots adjusted to various pH's with
0.5 M Tris-HCl, pH 9.0. One and a half volumes of
n-butanol were added to each sample, the mixtures
homogenized briefly and centrifuged for 10 min at 10,000 g.
The aqueous phases were aspirated and immediately assayed
for recovery of enzyme activity (mercaptide assay) and
protein (A ).
280
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(NH ) so fractionation. Optimization of (NH 4 )2so 4 fractionation
4 2 4
using the mercaptide assay is shown in Fig. 9. Routine purification
employed the whole 55-70% range.
Hydrophobic chromatography.

An elution profile of enzyme activity

(mercaptide assay) and protein (A 280 ) is shown in Fig. 10. Almost
half of the applied protein washed through the column with the
application buffer.

Enzyme, along with 5-10% of the protein, is

eluted at the breakthrough of the elution buffer.
Hydroxyapatite chromatography.
column is shown in Fig. 11.
enzyme activity.

Elution from the hydroxyapatite

The mercaptide assay was used to measure

All fractions containing significant protein were

pooled as a constant specific activity was observed.
Characterization
Intracellular Distribution
The apparent in t ra cellular distribution of pantetheine hydrolyzing
activity and glucose-6-phosphatase, a microsomal marker, are shown in
Fig. 12.

Data are presented graphically in the manner proposed by

DeDuve et al. (1955).

The area of each block is proportional to the

percentage of activity recovered in the corresponding fraction, and
its height to the degree of purification achieved over the homogenate.
Michaelis Constant, pH Profile, and
Molecular Weight
Kinetic plots after Hanes (1932) reveal an apparent Km of 20 µM
A similar X was obtained for
m
0-pantetheine with substrate added as OL-pantetheine. Particulate
for 0-pantetheine (Fig. 13).
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Optimization of (NH 4 ) 2so 4 fractionation. Aliquots of the
supernatant from Step 4 cf the purification (page 37) were
brought to between 55% and 70% saturated by adding solid
(NH 4 ) 2 S0 . The suspensions were centrifuged for 30 min at
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g4to recover pellets containing various amounts of
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enzyme (Step 2 of the purification) had an apparent Km of 50 µM using
the pantothenate assay (data not shown).
The pH profile of enzymatic activity (Fig. 14) shows a broad
plateau between pH 3 and 7.
at pH 9 to 9.5.

Activity increases above pH 7 to a peak

The basic optimum was not an artifact of more

efficient enzyme activation at higher pH, because enzyme reduced at pH
9 gave similar results.

Particulate enzyme (Step 2 of the

purification) also showed a similar pH optimum (data not shown).
Molecular weight (MW) estimations of the enzyme by sodium
dodecylsulfate (SOS) electrophoresis and gel filtration are shown in
Fig. 15.

Gel filtration gave an apparent MW of 54,000 while SOS

electrophoresis indicated 60,000.

The average (57,000) was used as

the best estimate of the actual MW.
Substrate Specificity
Verification of analog structure.

The proton magnetic resonance

(pmr) spectra of pantethine is shown in Fig. 16.

Spectra of the

analogs varied from pantethine in a predictable and systematic way.
Stick pmr spectra of pantethine and some of the more interesting
analogs are given in Fig. 17.
Specificity studies.

Substrate specificities of the purified pig

kidney enzyme (Step 7) and a homogenate of chicken liver are shown in
Table 8.

Chicken liver homogenates hydrolyze pantetheine 3 times

faster than CoA.

The pig kidney enzyme requires unchanged 0-pantoyl

and s-alanyl moieties for significant hydrolysis to occur.

0.3 1 - - - - - - - - - - - - - - - - - - Iii · gly cine HCI
o - format e
• - ace tat e
" - phosphate

• - tris · HCI
o- borate
• - carbonate

0.2
0
0

C"'.l

<(

0 .1

/'o·

•

•

...

/

0.0~-~--~-~~--'---1---L--.&...--JL.....I
9
2
3
4
5
6
7
8
10

PH
Figure 14. The pH profile of enzymatic activity. (NH) SO enzyme solution (12.5 µl) was prereduced
with 10 mM dithioerythritol in 17 mM Tris-Act, iH 8.1, for 20 min at 37°C in a volume of
150 µl. Fifty microliters of 0.5 M buffer with 295 µl of H?O was added and the reaction
initiated with 5 µl of 100 mM 0-pantetheine. Analysis followed the cysteamine assay
(page 34). Pantethine blanks have been subtracted.
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Table 8.

Substrate Specificity.

Substrate
0-Pantetheine

Percent Activity
Chicken liv~r
Pig kidney enzyme
homogenate
step 7
(100)

(100)

Analogb
AI (N-acetylcysteamine)

<5

All (S-alethine diHCl)

<2

AIII (CoA)

36

<0.5

BI (N,N'-bis[pantoyl] cystamine)

<2

BII (N,N'-bis[pantoylglycyl] cystamine)

<2

BIII (N,N'-bis[pantoyl-y-aminobutyryl] cystamine)

<l

CI (pantothenyl-s-aminoethanol)

75

CII (S-ethyl pantetheine)

80

CIII (N,N'-bis[pantothenyl]-1 ,6-diaminohexane)

96

aChicken liver (Pel Freeze, Rogers, Ark.) was homogenized with 4
volumes of 0.04 M Tris-HCl, pH 8.2.
bDisulfide analogs are routinely reduced during assay prior to
exposure to enzyme.
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Modification of the cysteamine portion is much less important; analogs
in the C series were all hydrolyzed at greater than 50% the rate of
0-pantetheine.
Polyacrylamide Gel Electrophoresis
Protein staining of the last 3 enzyme purification steps following
nondenaturing electrophoresis is shown in Fig. 18.
electrophoresed to a relatively wide band at Rf

=

Enzyme is
0.3-0.4.

Protein,

carbohydrate, and activity stains of the purified enzyme after
nondenaturing electrophoresis are shown in Fig. 19.

Staining occurs

at the same Rf by each technique, although the activity stain appears
over a wider range.

Protein and carbohydrate stains of the purified

enzyme after sodium dodecylsulfate electrophoresis are shown in Fig.
20.

Protein and carbohydrate co-electrophorese under denaturing

conditions.
Amino Acid and Carbohydrate
Composition
Typical elution profiles of amino acid and hexose analysis are
shown in Fig. 21 and Fig. 22, respectively.

The variation in apparent

amino acid content with hydrolysis time is shown in Fig. 23.
Extrapolation of values in Fig. 23 as indicated in Chapter III, along
with average values for the other amino acids, gives a protein
1% (A
absorbancy index for the enzyme, Elem
280 ), of 11.3. The apparent
amino acid and carbohydrate composition per mole of enzyme is given in
Table 9.

Using the average of the two galactosamine estimations, the

apparent carbohydrate content of the enzyme is 11.8% by weight, and
its turnover number is 12/sec in terms of 0-pantetheine.
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44.

-...J

N

Cl>

20"'

RI

-;;

Cl>

c"'

Cl>

0

"'c0

"'Cl>
a:

RI

a.

C)

c

~

0

Cl>

;:;

c
.E
RI
"'0

Cl>

w

a

ti

Cl>

Cl>

>

"'0

.!!!

u..

<-'

RI

0
::J

RI
Cl>

a:

0

15

30

45

60

Time After Injection (min)

Figure 22. Gas chromatography of hexose alditol acetates following glycoprotein hydrolysis and
hexose reduction and acetylation. See page 44 for details of preparation and analysis.

1000

0

00

• - lsoleucine
o -Valine
x -Serine
• - Threonine
o - Cysteine
• - Galactosamine

800

N

<(
........

•

•

•

0

E
c

600

.....

0

c

(I)

0

0

.....
c
0

u
""O
0

<(

x

•

400

•

0

c

x

E

<( .
+-'

c

(I)
._

200

ro

0

.

0..
0..
<(

0

0

..

..

0
0

20

40

60

80

Hydrolysis Time (hours)

Figure 23. Variation in apparent amino acid content with hydrolysis time. Enzyme was hydrolyzed for
varying periods of time with 4 N methanesulfonic acid after Simpson et al. (1976) and
amino acids separated on a 60 cm column of Durrum DC-lA resin with norleucine as internal
standard. See page 44 for details.

75
Table 9.

Amino Acid and Carbohydrate Composition.

A~~arent

Residue
Ha lf-cysb
Asx
Thr
Ser
Glx
Pro
Gly
Ala
Val
Met
Leu
Ile
Tyr
Phe
Lys
His
Arg
Trp

moles

~er

mole (57,000 g) of

Ami no Acid Analysis

GCa

7.6
25.3

Fucose
Mannose
Ga lactose
Glucose

Sialic Acide

Other

9.8
42.9
24.4
26.0
37.8
24.9
26.5
28.3
31.0
10.4
18.7
49.9
17.3
32.8
17.7
16.5
19.7

Neutral Hexoses

Galactosaminec

gl~co~rotein

3.5
9.2
9.5
3.0

s .ad

3.3

6.8
4.5

aCalculated by equating the total area of the fucose, mannose,
galactose, and glucose peaks with the neutral hexose determination
and assuming proportionality between peak areas and the mass of
carbohydrate present.
bDetermined as S-sulfocysteine.
cCalculated as N-acetylgalactosamine.
dDetermined by linear extrapolation of values at 22 and 48 hours of
hydrolysis to zero time.
eCalculated as N-acetylneuraminic acid.
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Comparison of Amidase Preparations
The properties of various amidase preparations are shown in Table
10.

Resin treatment successfully removed 80-90% of the pantothenate

in pigeon and chicken liver acetone powder.

However, hog kidney

acetone powder could not be prepared without gross loss of enzyme
The (NH 4 ) 2so 4 enzyme solution of hog kidney has negligible
pantothenate content, a specific activity of over 100 times other

activity .

preparations, and greater than 80% of its activity remains after 8
hours at 37°C.
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Table 10.

Properties of various Amidase Preparations.

Source

Activitya
(units/ml)

Pantothenateb Sp. Act. c Stabilityd
(%)
(ng/unit)
(units/mg)

Pigeon Liver
Acetone eowdere
Resin treated

28
4.8

410
81

1. 7
0.80

48
63
23

240
180
19

1.5
1. 9
1.8

57

4. l
0.5
460

83
82

56

Chicken Liver
Homogenatef
Acetone eowderg
Resin treated

75

Hog Kidne,t
Homogenatef
Acetone powderg
(NHB)tso enzyme
sol t on 4

124
17
600

54
470
<O. l
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aEnzyme activity was measured by the pantothenate assay. A unit is
defined as the amount of enzyme that will liberate l nmole of
pantothenate per minute.
b"Total" pantothenate was liberated by adding an excess of calf
intestinal phosphatase (Sigma, Type VII). Pantothenate was measured
by radioimmunoassay as in the pantothenate enzyme assay.
cProtein was measured by the method of Lowry et al. (1951).
dGiven as the percent activity remaining after incubation at 37°C for
8 hours.
ePurchased commercially (Sigma).
fHomogenization was with 4 volumes of 0.02 M Tris, pH 8.2.
gAcetone powders of chicken liver (Pel Freeze, Rogers, Ark.) and fresh
hog kidney were prepared by the method of Kaplan and Lipmann (1948)
and resin treated after Novelli and Schmetz (1951). Commerical
chicken liver acetone powder (Sigma) had 43 % of the listed activity.
Commerical porcine kidney acetone powder (Sigma, Type II) had less
than 20% of the listed activity.
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CHAPTER V
DISCUSSION
The objectives of this study include development of rapid and
reliable assays, routine purification to homogeneity, and
characterization of a pantetheine hydrolyzing enzyme.

Four rapid,

independent assays of pantetheine hydrolysis have been described and
compared along with a method for localizing enzymatic activity on
polyacrylamide gels.

A microsomal enzyme from pig kidney cortex was

purified 5600-fold in 22% yield to apparent homogeneity on SOS
electrophoresis.

Carbohydrate co-electrophoresed with the purified

protein and individual amino acid and carbohydrate residues were
quantified.

The Km for 0-pantetheine was 20 µM and substrate

specificity was high for the pantothenate moiety, but not for the
cysteamine portion.

Properties of the enzyme indicate it should be

ideal for liberation of pantothenate from biological tissues.

Radiolabeled Assay
The radiolabeled assay resembles that previously reported (Dupre
et al. 1970a; Dupre and Cavallini, 1979).

However, labeled

0-pantethine is used as substrate instead of DL-pantethine, a 15-min
chromatography step is used instead of 5 hours of electrophoresis to
separate labeled substrate and product, and enzyme and substrate are
prereduced before assay.

Enzyme prereduction is necessary for linear
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initial velocities as shown by Fig. 6 and the product vs time curve of
Dupre et al. (Dupre et al. 1970a).

Preliminary experiments on enzyme

prereduction using the radiolabeled assay indicated an optimum
concentration of dithioerythritol between ca. 7 and 70 mM when
reduction occurred for 20 min at 37°C.

Figure 6 shows reduction is

still incomplete after 20 min at 37°C with l mM dithioerythritol.

A

concentration of 10 mM dithioerythritol was subsequently used for all
enzyme preincubation.
The chromatographic separation in the radiolabeled assay is
unusual because of its nonequilibrium nature.

Solvent continually

evaporates from the solvent front and migrating components are
concentrated to a sharp band at the front.

Application to other

bipartite separations is possible by modifying the solvent system.
For example, aletheine can be separated from pantothenic acid and
pantetheine by using acetone/0.1 N HCl (90/10). With [ 14 c] pantethine
labeled on the a-alanine portion, this separation can be used after
exhaustive enzyme hydrolysis to verify which amide bond in pantetheine
is hydrolyzed.

It is also apparent from Fig. 4 and the specific

nature of the pantothenate and cysteamine assays that hydrolysis
occurs between pantothenate and cysteamine, and not between pantoate
and aletheine . . This specificity has already been demonstrated for the
enzyme from horse kidney (Dupre et al. 1970b).
Pantothenate Assay
The pantothenate assay is based on a radioimmunoassay specific
for pantothenate (Wyse et al. 1979).

Cross-reaction of the antiserum

with pantetheine occurs at concentrations of pantetheine ca. 500 times
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[ 14 c] Pantothenate was used
instead of the originally published 3H label because the tritiated

greater than that of pantothenate.

form required frequent chromatographic purification and its higher
specific activity improved the assay sensitivity only slightly.
Antibody-bound and free hapten were simply and rapidly separated by
nitrocellulose filters, a method introduced by Gershman et al. (1972).
The technique used here is unique because both antibody-b·ound and free
hapten are analyzed.

It was necessary to have the solution and wash

ice cold for filtration to prevent antigen-antibody dissociation.
This may be due to the relatively low association constant of the
antisera (ca. 10 7 M- 1 ). Although the most time-consuming assay
presented, 16 samples can be processed in less than 2 hours (excluding
counting

~ime).

Enzyme blanks must be subtracted if the enzyme

contains significant pantothenate.
Cysteamine Assay
The cysteamine assay is based on the observation by Avi-Dor and
Mager (1956) that thiols and aminoethanethiols react differently with
fluoropyruvate to form products with characteristic uv spectra.
Alkylthiols without a free 8-amino group form alkylthiopyruvates
(Bergmann and Mielewitz, 1963), which absorb maximally around 270 nm
(£

=

540 for glutathione).

Aminoethanethiols give thiazines with a

peak absorption at about 300 nm (£

=

5200 for cysteine).

These

findings were later applied to quantitation of aminoethanethiols in
biologic media (Herrington et al. 1967).

This method has been

modified for maximal reacti on in 10 min by increasing the
concentration of fluoropyruvate and performing the reaction at 37°C
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instead of at ambient temperature.

Enzyme blanks must be subtracted

if the enzyme contains significant fluoropyruvate reactive material.
Mercaptide Assay
The mercaptide assay is based on the uv absorption of the
mercaptide ion and the different pK values (-SH) of pantetheine and
cysteamine.

The mercaptide ion has a peak absorption around 235 nm of
ca. 5000 M-l cm- 1 (Benesch and Benesch, 1955). Using the
spectrophotometric pK determination of Benesch and Benesch (1955) the
pK (-SH) of pantetheine was 9.9, and that of cysteamine 8.1, at 37°C.

The cysteamine value is similar to previous reports (Danehy and Noel,
1960).

A comprehensive literature search failed to reveal a previous

determination f?r the pK of pantetheine.
The mercaptide ion was monitored at 240 nm because of rapidly
increasing end absorption of protein below this value.

At 240 nm the

absorbance of protein (bovine serum albumin) is 1.6 times that at 280
nm.

The highest sensitivity for the mercaptide assay would be

obtained at a pH of 9.0, halfway between the pK values (-SH) of
pantetheine and cysteamine.

However, we used a buffer pH of 8.1 as a

compromise between increasing assay sensitivity and enhanced blank
absorption with increasing pH.

At pH 8. l, over 60% of the maximal

sensitivity is obtained, with less than 25% of the blank absorption
found at pH 9.0.

A lower pH also reduces the rate of thiol oxidation.

Dithioerythritol was used instead of dithiothreitol because of its
higher pK values (Zahler and Cleland, 1968) and, therefore, lower
contribution to blank absorption.
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Reduction Requirements
The presence of dithioerythritol in the cysteamine and mercaptide
assays is critical.

Concentrations were chosen to minimize blank

absorption, yet insure complete reduction of cysteamine.

In the

mercaptide assay, the slow oxidation of dithioerythritol is measured
by a downward drift in the A
(less than 0.001/min with adequate
240
deoxygenation) before addition of substrate. On substrate exhaustion,
the tracing returns to the same slow downward drift.

In the

cysteamine assay, the extent of dithioerythritol oxidation is
unimportant, as oxidized dithioerythritol absorbs at 300 nm to the
same extent as the fluoropyruvate adduct of reduced dithioerythritol
(Herrington et al. 1967).

The success of these two assays depends on

the ability of dithioerythritol to maintain cysteamine in the reduced
state (Cleland, 1964).

Mercaptoethanol and NaBH 4 were not as
effective in keeping cysteamine reduced.
Comparison Between Assays
The radiolabeled, pantothenate, and cysteamine assays can be used
to monitor enzyme activity at any stage of purification.

However,

enzyme blanks must be subtracted from the pantothenate and cysteamine
assays during initial fractionation when these substances contaminate
the enzyme.

Comparison between assays for the beginning and ending

stages of purification are given in Table 6.

The pantothenate and

cysteamine assays are particularly useful in the study of substrate
specificity.

The mercaptide assay is most convenient and precise, but

its use is limited to steps after enzyme solubilization.

Particulate

fractions cause instability in the absorbance reading and high protein
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content results in high blank absorption.
inferred from the data in Table 5.

Assay sensitivity can be

The sensitivity of the

radiolabeled assay can be varied by using labeled pantethine of
different specific radioactivity.
Purification
The purification from pig kidney uses predominantly batch
operations with only two chromatographic steps requiring simple step
The (NH ) so enzyme solution (Step 5) can be produced in
4 2 4
less than 6 hours. The remaining steps take an additional 12 hours.

elution.

Microsomal pH agglutination was chosen over high speed centrifugation
because larger quantities could be produced in the same time with less
costly equipment.

Butanol treatment (Morton, 1950) effected

solubilization, whereas detergent treated microsomes still spun down
activity at 100,000 g.
There are only a few critical steps in the purification.

The pH

of the suspension before butanol treatment is important (Figure 8).
Recovered activity drops precipitously below pH 5.75.

The temperature

of the hydrophobic chromatography column is also critical and must be
kept at 0-4°C.

At 5-l0°C most of the activity will pass through the

column during initial washing.

Minor variation in other steps makes

little difference.
Dupre and Cavalinni (1979) report a 16,000-fold purification to
homogeneity of a pantetheine hydrolyzing enzyme from horse kidney.
The purification reported here from pig kidney is 5600-fold.
Comparisons of specific activities are shown in Table 11.

Protein and
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Table 11.

Specific Activity Comparisons of Horse and Pig Kidney
Purifications.

Specific Activity
(nmol pantothenate/min/mg)
Purified Enzyme
Homogenate

Source

Horse kidney (Dupre and
Cavallini, 1979)

0.025

Pig Kidney (Table 7)

2.5

400
14,000

activity assays vary in Table 11, but correction requires less than a
factor of 2 and can be calculated from Table 6.

The marked apparent

difference between horse and pig kidney is suprising.

The horse

kidney homogenate specific activity may be underestimated as implied
in Chapter II (Table 3).

A 35-fold difference in the purified

enzyme's specific activity is harder to explain.
Characterization
Characteristics of the enzyme purified from pig kidney are
compared to previously studied preparations in Table 12.

The

molecular weight and heat stability of the enzyme are similar to that
from horse kidney (Dupre and Cavallini, 1979).

However, the pH

profile and K are more similar to values from rat kidney (Abiko,

m

1975).

All three preparations show similar substrate specificity, but

there is a wide variation in maximum specific activities and
absorbancy indexes.
been reported.

The presence of carbohydrate has not previously

Table 12.

Comparative Summary of Purifi ed Amidase Preparations.

Parameters a

Horse Kidney
{Dupre and Cavallini, 1979)

Subcellular Localization
Km (mM 0-pantetheine)
pH Optimum
Molecular Weight
Maximum Specific Activity
(nmol pantothenate/min/mg protein)

MicrosomalLysosomal

1%

Pig Kidneya
Microsomal

5.0

0.04

0.02

4.0-5.5

7.0

9.0-9.5

55,000 (Ultracent.)
400

Carbohydrate Content (%)
Elcm(280 nm)

Source
Rat Kidney
(Ab i ko , l 975 )

54,000 (Gel Filt.)
60,000 (SOS Gel Elect.)
19

14,000
11.8

15.2

11. 3

aSee Chapter III for methods of determination and purification.

co
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Subcellular Localization
Subcellular fractionation shows the enzyme apparently
distributing to both the lysosomal and microsomal fractions (Fig. 12)
as concluded by Abiko (1975).

However, the microsomal marker,

glucose-6-phosphatase, also distributes in the same manner.

The

fractionation scheme used was originally developed for liver tissue
(DeDuve et al. 1955).

When applied to kidney tissue, microsomal

proteins distribute in the pattern shown in Fig. 12 (Ali and Lack,
1965).

Therefore, the enzyme from pig kidney is mainly, if not

exclusively, microsomal.
Michaelis Constant, pH Profile, and
Molecular Weight Determination
The reported K for the horse kidney enzyme is over 100 times
m
other preparations (Table 12). DL-Pantetheine instead of
0-pantetheine was used in kinetic studies of the horse kidney enzyme.
However, Fig. 13 shows this should not change the Km determination.
Although the presence of the L-isomer inhibits mildly at high
concentrations, similar kinetic intercepts are obtained by
extrapolation.
The smooth curve of the pH profile by the cysteamine assay is
shown in Fig. 14.

The pH profile of Dupre et al. (1970b) does not

cover the alkaline range.

The profile of Dupre et al. (1976) is, a)

inaccurate in the neutral range because of the nature of the pH-stat
assay, and b) depressed in the alkaline range because of incorrect pK
assignments of the functional groups in cysteamine (Benesch and
Benesch, 1955).
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All molecular weight determinations given in Table 12 are within
close limits.

However, both the gel filtration (Andrews, 1965) and

the SOS gel electrophoresis (Segrest and Jackson, 1972) estimates may
be overestimated because of the presence of carbohydrate.

Caution in

interpretation should await more definitive studies.
Substrate Specificity
Chicken liver preparations prefer pantetheine to CoA (Table 8).
This contradicts the impression of Novelli et al. (1954) that avian
liver enzymes prefer CoA.

The specificity may be even greater than

shown in Table 8 as phosphatases endogenous to the homogenate may be
converting CoA to pantetheine.
All kidney preparations have shown high specificity (Chapter II
•

and Table 8).

However, Table 8 reveals that minor variations in the

cysteamine moiety can be made with retention of enzymatic activity.
Extended pantetheine molecules, such as S-acyl pantetheine derivatives
may be active or even better substrates for the enzyme.
The diaminohexane derivative (Analog CIII) is a very close analog
of pantethine.

A hydrocarbon chain replaces the disulfide bridge.

The ready hydolysis of the molecule (Table 8) suggests that
pantethine, as well as pantetheine, is a substrate for the enzyme.
Polyacrylamide Gel Electrophoresis
Co-elution of protein, activity, and carbohydrate, and purity of
the glycoprotein are shown under
conditions in Figs. 18-20.

denatur~ng

and nondenaturing

At Step 5 in Fig. 18, only one major

protein band is present at an Rf slightly greater than the purified
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glycoprotein.
at this stage.

It would be easy to think purification nearly complete
The specific activity of Step 5 is 350 nmol/min/ml,

similar to the maximum specific activity of 400 nmol/min/ml of Dupre
and Cavallini (1979).
Localization of activity on polyacrylamide gels.

Activity

electrophoresed on polyacrylamide gels can be visualized by titration
of an indicator because the enzymatic reaction produces acid at pH's
intermediate to the pK's (-SH) of pantetheine and cysteamine.

The

Tris gel buffer is first diluted by dialysis against H20. Pantetheine
and cresol red are added and the solution titrated with NaOH just to
the basic side of the indicator.

Cresol red and substrate diffuse

into the gel and acid produced by the hydrolysis of pantetheine
locally titrates the indicator.

Resolution is limited by diffusion.

Amino Acid and Carbohydrate
Analysis
Carbohydrate analysis of the glycoprotein is consistent with
oligosaccharide chains linked 0-glycosidically through N-acetylgalactosamine to the hydroxy group of serine or threonine (Kornfeld
and Kornfeld, 1976).

Isoleucine and phenylalanine occur in amounts

exceeding twice that f ound in the average protein (Dayhoff, 1978).
Increased amounts of these hydrophobic amino acids is suggestive of an
integral membrane protein.
The specific values for amino acid and carbohydrate composition
in Table 9 should be interpreted cautiously.

The whole table depends

on the accuracy of the molecular weight determination which is subject
to overestimation as prev iously mentioned.

Values for specific sugar
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residues additionally depend on several assumptions listed in the
footnotes of Table 9.

The different absorbancy indexes listed in

Table 12, 15.2 and 11.3, were both determined by amino acid analysis
and suggest a fundamental difference in the amino acid content of the
two preparations.
Use of Various Amidase Preparations
in Pantothenate Liberation
The (NH ) so enzyme solution has several properties which make
4 2 4
it ideal for use in 11 total 11 tissue pantothenate determination (Table
10).

It has over 100 times the specific activity and less than 1/100

the pantothenate content of other preparations. It is easily prepared
and highly stable.

On the other hand, the stability of the avian

liver preparations is suprising in view of previous reports of their
lability (Chapter I).

Avian liver preparations should be adequate for

most applications when sensitivity does not require low enzyme
pantothenate.
Future Studies
This dissertation provides the methodology necessary to approach
the concerns of Chapter I.

The enzyme assays should be useful in

evaluating the significance of pantetheine hydrolysis in the
metabolism of coenzyme A.

For example, enzyme activity during the

elevated CoA levels of diabetes, fasting, and clofibrate
administration could be evaluated.
a well defined

11

The purified enzyme also provides

reagent 11 which could be used in developing schemes of

pantothenate liberation from various biologic sources.
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Consideration of the specific function of this enzyme in kidney
is only speculative.

However, delineation of its specificity for

S-acyl pantetheine derivatives is an intriguing area for further
research.
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